The present invention provides an industrially advantageous production method of (1R,2S)-2-{[((2,4-dimethylpyrimidin-5-yl)oxy}methyl]-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropane-1-carboxamide.

(1R,2S)-2-{[((2,4-Dimethylpyrimidin-5-yl)oxyl}methyl]-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropane-1-carboxamide (compound [A]) is produced by an industrially advantageous method by a route via a novel compound.

##STR00001##

wherein each symbol is as described in the description.

The present disclosure provides salts of lipoic acid choline ester (LACE), crystalline forms thereof, and methods of use thereof. The present disclosure further provides pharmaceutical compositions of LACE salts and methods of use thereof.

The present disclosure provides salts of lipoic acid choline ester (LACE), crystalline forms thereof, and methods of use thereof. The present disclosure further provides pharmaceutical compositions of LACE salts and methods of use thereof.

In an embodiment of the invention, a composition for treating a cell population comprises a medicant. The medicant moiety can be an illudofulvene analog. In an embodiment of the invention, a composition for treating a cell population comprises an Affinity Medicant Conjugate (AMC). The affinity moiety can be an antibody, an antibody fragment, a receptor protein, a peptidic growth factor, an anti-angiogenic protein, a specific binding peptide, protease cleavable peptide, a glycopeptide, a peptide, a peptidic toxin, a protein toxin and an oligonucleotide. The affinity moiety can be covalently bound to the medicant via a linker.

In an embodiment of the invention, a composition for treating a cell population comprises a medicant. The medicant moiety can be an illudofulvene analog. In an embodiment of the invention, a composition for treating a cell population comprises an Affinity Medicant Conjugate (AMC). The affinity moiety can be an antibody, an antibody fragment, a receptor protein, a peptidic growth factor, an anti-angiogenic protein, a specific binding peptide, protease cleavable peptide, a glycopeptide, a peptide, a peptidic toxin, a protein toxin and an oligonucleotide. The affinity moiety can be covalently bound to the medicant via a linker.

A fluorescent water treatment polymer comprises at least one water soluble carboxylic acid monomer other than maleic acid, at least one sulfonated pyrene-containing fluorescent monomer, and at least one phosphino group wherein the phosphorous atom of the phosphino group is in the polymer backbone. Additional monomers can be present, with the proviso that if maleic acid is present it comprises no greater than 75 mol % of the polymer. Surprisingly, it has been found that when the phosphino group is present the polymers exhibit an unexpectedly strong fluorescent signal strength. The signal strength of the fluorescent monomer in the polymer is further enhanced when the polymer comprises no greater than 75 mol % maleic acid.

The present invention relates to an electrolyte solution for a lithium secondary battery that includes an additive for forming a stable SEI film and a protective layer on a surface of an electrode to prevent a chemical reaction between the electrolyte solution and the electrode, and a lithium secondary battery having improved life characteristics and high-temperature stability by including the same.

The present invention relates to an electrolyte solution for a lithium secondary battery that includes an additive for forming a stable SEI film and a protective layer on a surface of an electrode to prevent a chemical reaction between the electrolyte solution and the electrode, and a lithium secondary battery having improved life characteristics and high-temperature stability by including the same.

Conformationally strained irans-cycloalkenes and derivatives thereof suitable for radiolabeling in a subject in need thereof.

The present invention relates to an electrolyte solution for a lithium secondary battery that includes an additive for forming a stable SEI film and a protective layer on a surface of an electrode to prevent a chemical reaction between the electrolyte solution and the electrode, and a lithium secondary battery having improved life characteristics and high-temperature stability by including the same.